In order to determine if there was a relationship between oncogenic RAS expression and S100A10 levels in clinically relevant cancer cells, we analyzed by western blotting, a panel of different cancer cell lines of which some express oncogenic RAS (Supplementary Figure S5). This evidence concerns the gene S100A10 and cancer.